iGlarLixi reduces HbA(1c) to a greater extent than basal insulin therapy regardless of HbA(1c) levels at screening-MedSci.cn

iGlarLixi reduces HbA(1c) to a greater extent than basal insulin therapy regardless of HbA(1c) levels at screening

Niemoeller, E; Souhami, E; Wu, Y; Jensen, KH

DIABETOLOGIA, 2017; 60 ( ): S370

科室
- - 订阅+
  - 更多科室
工具
服务